Source: FinanzNachrichten

Acticor Biotech: CORRECTING and REPLACING: Acticor Biotech Publishes Its Half-year Financial Results for 2024

Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: "The limited review procedures for the interim financial statements ha...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Gilles Avenard's photo - CEO of Acticor Biotech

CEO

Gilles Avenard

CEO Approval Rating

85/100

Read more